Neurocentria Welcomes Dr. Thomas Südhof to its Scientific Advisory Board
Neurocentria Announces Addition to Scientific Team WALNUT CREEK, Calif., Jan. 13, 2023 (GLOBE NEWSWIRE) — Neurocentria, Inc., a privately held late-stage biotechnology company, has recently appointed a new member to its scientific team. This addition further strengthens Neurocentria’s scientific resources, particularly in the areas of neuronal function and synaptic transmission. These areas are crucial to…